Estrogen receptor alpha-coupled Bmi1 regulation pathway in breast cancer and its clinical implications


Bmi1 has been identified as an important regulator in breast cancer, but its relationship with other signaling molecules such as ERalpha and HER2 is undetermined.

Methods:
The expression of Bmi1 and its correlation with ERalpha, PR, Ki-67, HER2, p16INK4a, cyclin D1 and pRB was evaluated by immunohistochemistry in a collection of 92 cases of breast cancer and statistically analyzed. Stimulation of Bmi1 expression by ERalpha or 17beta-estradiol (E2) was analyzed in cell lines including MCF-7, MDA-MB-231, ERalpha-restored MDA-MB-231 and ERalpha-knockdown MCF-7 cells.

Luciferase reporter and chromatin immunoprecipitation assays were also performed.

Results:
Immunostaining revealed strong correlation of Bmi1 and ERalpha expression status in breast cancer. Expression of Bmi1 was stimulated by 17beta-estradiol in ERalpha-positive MCF-7 cells but not in ERalpha-negative MDA-MB-231 cells, while the expression of Bmi1 did not alter expression of ERalpha.

As expected, stimulation of Bmi1 expression could also be achieved in ERalpha-restored MDA-MB-231 cells, and at the same time depletion of ERalpha decreased expression of Bmi1. The proximal promoter region of Bmi1 was transcriptionally activated with co-transfection of ERalpha in luciferase assays, and the interaction of the Bmi1 promoter with ERalpha was confirmed by chromatin immunoprecipitation.

Moreover, in breast cancer tissues activation of the ERalpha-coupled Bmi1 pathway generally correlated with high levels of cyclin D1, while loss of its activity resulted in aberrant expression of p16INK4a and a high Ki-67 index, which implied a more aggressive phenotype of breast cancer.

Conclusions:
Expression of Bmi1 is influenced by ERalpha, and the activity of the ERalpha-coupled Bmi1 signature impacts p16INK4a and cyclin D1 status and thus correlates with the tumor molecular subtype and biologic behavior. This demonstrates the important role which is played by ERalpha-coupled Bmi1 in human breast cancer.

Author: Huali WangHaijing LiuXin LiJing ZhaoHong ZhangJingzhuo MaoYongxin ZouHong ZhangShuang ZhangWei HouLin HouMichael A McNuttBo Zhang
Credits/Source: BMC Cancer 2014, 14:122

Published on: 2014-02-24

Tweet

News Provider: EUPB – European Press Bureau

Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo

There are no comments available. Be the first to write a comment.